Ciclesonide

Ciclesonide is a prodrug corticosteroid activated locally in the lungs and nasal mucosa. It is used for the treatment of asthma and allergic rhinitis. Its on-site activation provides high local anti-inflammatory activity with minimal systemic side effects. Mediocon Inc supplies pharmaceutical-grade Ciclesonide meeting IP/BP/EP/USP standards.

Key Features

• Prodrug corticosteroid – activated locally in airways
• IP/BP/EP/USP compliant, Assay 99.0% Min.
• Minimal systemic side effects
• Suitable for inhalation and nasal spray formulations

Applications

• Inhalation aerosol for asthma
• Nasal spray for allergic rhinitis
• Combination inhaler formulations
• Respiratory drug manufacturing

Why Choose Mediocon

• ISO 9001:2015 & GMP certified manufacturing
• Consistent batch-to-batch quality with full CoA
• Export-ready documentation: COO, MSDS, DMF
• Flexible MOQ for both R&D and commercial scale
• Dedicated QA support for regulatory filings